Suppr超能文献

西咪替丁和碳酸氢钠对囊性纤维化患者胰腺替代治疗的影响。

Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

作者信息

Durie P R, Bell L, Linton W, Corey M L, Forstner G G

出版信息

Gut. 1980 Sep;21(9):778-86. doi: 10.1136/gut.21.9.778.

Abstract

Fifteen patients with cystic fibrosis and pancreatic insufficiency were studied during four randomised seven day treatment periods in which they received only pancreatic supplement (Pancrelipase, 27 capsules per day) or supplement plus cimetidine (20 mg/kg body weight/24 h) or sodium bicarbonate (15 g/m2/24 h) alone or in combination. Dietary intake was not fixed but was restricted to foods of known fat and nitrogen content from which daily intakes could be computed. Faecal fat and nitrogen were calculated as g/24 h and percentage of intake. Addition of either cimetidine or bicarbonate resulted in significant improvement in fat and nitrogen excretion, which was not greater with the combination of both drugs. Cimetidine and sodium bicarbonate in these doses are therefore sufficient to produce maximal improvement in digestive activity of pancreatic supplements. Fat excretion per gram of intake fell with cimetidine and bicarbonate from 12 times the normal level, to normal, in patients consuming less than 120 g fat daily. Above this intake the dose of pancreatic supplement appeared to be inadequate. Faecal nitrogen excretion increased with nitrogen intake in all four periods, but, in contrast with fat excretion, the response to cimetidine and bicarbonate was not affected by the level of intake. Dietary intake appears to be a significant factor in determining the faecal output of fat and nitrogen in patients with pancreatic insufficiency and should be considered when determining the optimum amount of pancreatic supplementation.

摘要

对15名患有囊性纤维化和胰腺功能不全的患者进行了研究,研究分为四个随机的为期7天的治疗阶段,期间他们仅接受胰腺补充剂(胰脂肪酶,每天27粒胶囊),或补充剂加西咪替丁(20毫克/千克体重/24小时),或单独使用碳酸氢钠(15克/平方米/24小时)或联合使用。饮食摄入量不固定,但仅限于已知脂肪和氮含量的食物,据此可计算每日摄入量。粪便脂肪和氮以克/24小时及摄入量的百分比来计算。添加西咪替丁或碳酸氢钠均能显著改善脂肪和氮的排泄,两种药物联合使用时效果并未更佳。因此,这些剂量的西咪替丁和碳酸氢钠足以使胰腺补充剂的消化活性得到最大程度的改善。对于每日摄入脂肪少于120克的患者,服用西咪替丁和碳酸氢钠后,每克摄入量的脂肪排泄量从正常水平的12倍降至正常水平。超过此摄入量时,胰腺补充剂的剂量似乎不足。在所有四个阶段中,粪便氮排泄量均随氮摄入量的增加而增加,但与脂肪排泄不同的是,对西咪替丁和碳酸氢钠的反应不受摄入量水平的影响。饮食摄入量似乎是决定胰腺功能不全患者粪便中脂肪和氮排出量的一个重要因素,在确定胰腺补充剂的最佳用量时应予以考虑。

相似文献

5
The effect of cimetidine on maldigestion in cystic fibrosis.
J Pediatr. 1979 Mar;94(3):488-92. doi: 10.1016/s0022-3476(79)80609-5.

引用本文的文献

1
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物治疗。
Cochrane Database Syst Rev. 2021 Apr 27;4(4):CD003424. doi: 10.1002/14651858.CD003424.pub5.
2
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD008227. doi: 10.1002/14651858.CD008227.pub4.
4
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD008227. doi: 10.1002/14651858.CD008227.pub3.
5
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物疗法。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD003424. doi: 10.1002/14651858.CD003424.pub4.

本文引用的文献

3
"Break-through in cystic fibrosis".
Pediatrics. 1961 Mar;27:351-3.
10
Malabsorption of bile acids in children with cystic fibrosis.囊性纤维化患儿的胆汁酸吸收不良。
N Engl J Med. 1973 Nov 8;289(19):1001-5. doi: 10.1056/NEJM197311082891903.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验